<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03747640</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-SN-18-0885</org_study_id>
    <nct_id>NCT03747640</nct_id>
  </id_info>
  <brief_title>Self Transcranial Direct Current Stimulation and Mindfulness-based Meditation for Pain in Older Adults With Knee Osteoarthritis</brief_title>
  <official_title>Self Transcranial Direct Current Stimulation and Mindfulness-based Meditation for Pain in Older Adults With Knee Osteoarthritis (Self tDCS and Meditation for Knee Pain)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the feasibility and preliminary efficacy of a
      two-week self tDCS and mindfulness-based meditation for pain in older adults with knee
      osteoarthritis (OA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 28, 2018</start_date>
  <completion_date type="Actual">March 8, 2019</completion_date>
  <primary_completion_date type="Actual">March 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pain as assessed by a numeric rating scale for pain (NRS)</measure>
    <time_frame>baseline</time_frame>
    <description>The NRS assess average pain over the past 24 hours from 0 (no pain) to 100 (most intense pain imaginable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical pain as assessed by a numeric rating scale for pain (NRS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The NRS assess average pain over the past 24 hours from 0 (no pain) to 100 (most intense pain imaginable).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pain as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>baseline</time_frame>
    <description>The WOMAC ranges from 0 to 96, with higher scores indicating worse OA pain-related symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pain as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The WOMAC ranges from 0 to 96, with higher scores indicating worse OA pain-related symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by PROMIS anxiety-short form</measure>
    <time_frame>baseline</time_frame>
    <description>The 7-item PROMIS Anxiety Short Form assesses the pure domain of anxiety in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety-short form</measure>
    <time_frame>2 weeks</time_frame>
    <description>The 7-item PROMIS Anxiety Short Form assesses the pure domain of anxiety in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by PROMIS depression-short form</measure>
    <time_frame>baseline</time_frame>
    <description>The 8-item PROMIS Depression Short Form assesses the pure domain of depression in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by PROMIS depression-short form</measure>
    <time_frame>2 weeks</time_frame>
    <description>The 8-item PROMIS Depression Short Form assesses the pure domain of depression in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by PROMIS sleep disturbance-short form</measure>
    <time_frame>baseline</time_frame>
    <description>The 8-item PROMIS Sleep Disturbance Short Form assesses the pure domain of sleep disturbance in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of sleep disturbance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by PROMIS sleep disturbance-short form</measure>
    <time_frame>2 weeks</time_frame>
    <description>The 8-item PROMIS Sleep Disturbance Short Form assesses the pure domain of sleep disturbance in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of sleep disturbance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by the Pain Catastrophizing Scale (PCS)</measure>
    <time_frame>baseline</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) consists of 13 items assessing three components of catastrophizing: rumination, magnification, and helplessness. Each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time).The PCS total score is computed by summing responses to all 13 items, with total scores ranging from 0 - 52. Higher scores indicate a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by the Pain Catastrophizing Scale (PCS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) consists of 13 items assessing three components of catastrophizing: rumination, magnification, and helplessness. Each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time).The PCS total score is computed by summing responses to all 13 items, with total scores ranging from 0 - 52. Higher scores indicate a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by the Freiburg Mindfulness Inventory (FMI)</measure>
    <time_frame>baseline</time_frame>
    <description>The Freiburg Mindfulness Inventory (FMI) is a 14-item instrument. Respondents indicate their experiences relating to the items on a 4-point Likert scale (rarely, occasionally, fairly often and almost always), and the total score is calculated by adding all the scores on the 14 items of the FMI. Total scores range from 14-56, with higher scores indicating higher levels of mindfulness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial symptoms as assessed by the Freiburg Mindfulness Inventory (FMI)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The Freiburg Mindfulness Inventory (FMI) is a 14-item instrument. Respondents indicate their experiences relating to the items on a 4-point Likert scale (rarely, occasionally, fairly often and almost always), and the total score is calculated by adding all the scores on the 14 items of the FMI. Total scores range from 14-56, with higher scores indicating higher levels of mindfulness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experimental pain sensitivity as assessed by conditioned pain modulation</measure>
    <time_frame>baseline</time_frame>
    <description>In order to measure experimental pain sensitivity, Conditioned Pain Modulation (CPM) will be completed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experimental pain sensitivity as assessed by conditioned pain modulation</measure>
    <time_frame>2 weeks</time_frame>
    <description>In order to measure experimental pain sensitivity, Conditioned Pain Modulation (CPM) will be completed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-related cortical response as assessed by functional near-infrared spectroscopy (fNIRS)</measure>
    <time_frame>baseline</time_frame>
    <description>Pain-related cortical response will be measured using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) with three semiconductor lasers at 780, 805, and 830 nm. Optical recordings will be collected during thermal pain stimulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-related cortical response as assessed by functional near-infrared spectroscopy (fNIRS)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain-related cortical response will be measured using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) with three semiconductor lasers at 780, 805, and 830 nm. Optical recordings will be collected during thermal pain stimulation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>tDCS with mindfulness-based meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Self Transcranial Direct Current Stimulation (tDCS) with Mindfulness-Based Meditation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS with sham meditation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham self Transcranial Direct Current Stimulation (tDCS) with sham Meditation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Self Transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <description>tDCS with a constant current intensity of 2 milliamps (mA) will be applied for 20 minutes per session daily for 2 weeks (Monday to Friday) via the Soterix 1x1 tDCS mini-CT Stimulator device (Soterix Medical Inc., New York; 6.5 inches long, 3 inches wide, 0.7 inches thick) with headgear and 5x7 cm saline-soaked surface sponge electrodes.</description>
    <arm_group_label>tDCS with mindfulness-based meditation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mindfulness-based meditation</intervention_name>
    <description>The meditation intervention will be delivered by a recorded device that participants will be given together with the tDCS. All meditation instruction recordings will be done by an experienced mind-body intervention specialist and installed in a user-friendly MP3 player.</description>
    <arm_group_label>tDCS with mindfulness-based meditation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Self Transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <description>For sham stimulation, the electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds.</description>
    <arm_group_label>sham tDCS with sham meditation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>sham meditation</intervention_name>
    <description>For sham meditation, the participants will be instructed, approximately every 2-3 minutes, to take deep breaths as we sit in meditation. Time spent giving instructions in the sham meditation intervention will be matched to time spent in the mindfulness intervention.</description>
    <arm_group_label>sham tDCS with sham meditation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  self-reported unilateral or bilateral knee OA pain, according to American College of
             Rheumatology criteria. According to American College of Rheumatology criteria,
             participants should meet at least 3 of 6 criteria, including age &gt; 50 years, stiffness
             &lt; 30 minutes, crepitus, bony tenderness, bony enlargement, and no palpable warmth.

          -  have had knee OA pain in the past 3 months with an average of at least 30 on a 100
             Numeric Rating Scale (NRS) for pain

          -  can speak and read English

          -  have a device with internet access that can be used for secure video conferencing for
             real-time remote supervision

          -  have no plan to change medication regimens for pain throughout the trial

          -  are able to travel to the coordinating center

          -  are willing and able to provide written informed consent prior to enrollment

        Exclusion Criteria:

          -  Participants will be excluded if they have concurrent medical conditions that hinder
             the completion of the protocol, including any of the following

          -  history of brain surgery, brain tumor, seizure, stroke, or intracranial metal
             implantation

          -  serious medical illness, such as uncontrolled hypertension (i.e., systolic blood
             pressure/ diastolic blood pressure â‰¥ 150/95 mm Hg), heart failure, or history of acute
             myocardial infarction

          -  alcohol/substance abuse

          -  cognitive impairment

          -  pregnancy or lactation

          -  hospitalization within the preceding year for psychiatric illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyochol Ahn, PhD, RN, MSN</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 16, 2018</study_first_submitted>
  <study_first_submitted_qc>November 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <disposition_first_submitted>February 5, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>February 5, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 10, 2020</disposition_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Hyochol Ahn</investigator_full_name>
    <investigator_title>Associate Professor &amp; Theodore J. and Mary E. Trumble Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

